While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and rollout of new drugs.

Citi reaffirmed its Buy rating on Sherwin-Williams (NYSE:SHW) stock, maintaining a $415.00 price target. The $90.8 billion paint and coatings company, which maintains a "GREAT" financial health score ...